Advantage Alpha Capital Partners LP Xencor Inc Transaction History
Advantage Alpha Capital Partners LP
- $440 Million
- Q2 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Xencor Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 42,871 shares of XNCR stock, worth $862,135. This represents 0.18% of its overall portfolio holdings.
Number of Shares
42,871
Previous 47,375
9.51%
Holding current value
$862,135
Previous $1.05 Million
22.61%
% of portfolio
0.18%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$223 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$183 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$141 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$107 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$79.7 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.2B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...